Europe

Mon
05
Jun

Marijuana cured 12-year-old girl of rare epilepsy syndrome

Annalise Lujan was in the middle of a gymnastics meet in April when she started vomiting and lost all feeling in her legs. 

As the 12-year-old fell into a crippling seizure, her parents rushed her to the hospital, and she was put into a medically induced coma to save her brain from damage. 

Annalise was then flown to a specialist unit at Phoenix Children's Hospital, where she was diagnosed with a rare epilepsy syndrome, known as febrile infection-related epilepsy syndrome (FIRES).

The condition causes Annalise to have seizures continuously, which can lead to brain injury and even death. It meant doctors couldn't bring her out of the coma until they had an effective method to prevent her seizures.

Mon
05
Jun

Green dreams: the growing case for medical marijuana in the UK

Nicky Haynes has almost forgotten the pain she used to be in. She has been taking Sativex, a drug derived from cannabis, for about five years and says it has hugely improved her life. She was diagnosed with multiple sclerosis in 1994, and her condition progressively worsened to the point where she couldn’t sleep, where reaching for a glass of water would trigger a spasm and she was in constant pain. The first time she took Sativex was during a long car journey, fearful that she wouldn’t be able to walk when she got out. But she was able to walk better than she had for a long time.

Wed
31
May

Germany: The Global Cannabis Movement Continues

Germany is becoming a hotbed for Canadian cannabis producers and we think this trend is just getting started. 

Germany, the largest country in the European Union started 2017 by legalizing medical cannabis creating a major opportunity for cannabis businesses across the world. The legislation also will make cannabis available to people suffering from serious illnesses and available through health insurance plans.

These factors have led to a surge in the number of licensed Canadian medical cannabis producers focused on this market and we want to highlight some of the recent deals.

Aurora Makes Major Acquisition

Wed
31
May

OWC Pharmaceutical Research Corp. Enters Into a Strategic Relationship With Germany-Based mediq Innovation Experts

The Initial Objective of the Collaboration is the Introduction of OWC's Active Cannabinoid-Based Topical Psoriasis Cream to the German Market.

OWC Pharmaceutical Research Corp. (OTC: OWCP) and mediq Innovation Partners (mediq) are pleased to announce an agreement for the introduction of OWCP's active cannabinoid-based topical psoriasis cream to the German market.

Frankfurt, Germany-based mediq has extensive experience, knowledge and a successful track record in enabling Israel-based companies to penetrate the European markets. mediq's objectives for OWCP will consist of both scientific collaboration and most importantly the development of a commercial market for OWCP's proprietary, active cannabinoid-based topical psoriasis cream in Germany.

Tue
30
May

France Wants to Scrap Prison Terms for Cannabis Use

France will introduce a new law by the end of the year to soften punishments for cannabis use, officials say.

The legislation, a key promise of President Emmanuel Macron’s election campaign, will end prison terms for marijuana consumers.

But the changes will stop short of decriminalising use of the drug, according to government spokesman Christophe Castaner.

France is one of half-a-dozen countries in the EU that still criminalises cannabis use, in contrast to Portugal.

Mon
29
May

Aurora Cannabis acquisition of German marijuana wholesaler could be a game changer

Aurora Cannabis Inc. (TSXV: ACB) announced just before Friday’s closing bell that it plans to acquire Germany’s Pedanios GmbH, a wholesale importer, exporter, and distributor of medical cannabis in the European Union (EU). Aurora Cannabis’ stock had been halted for more than 24 hours pending this news.

Mon
29
May

Oui: France to decriminalize Marijuana

France intends to soon stop prosecuting marijuana possession with years of imprisonment, according to a statement by GĂ©rard Collomb, the newly appointed interior minister.

Under new rules that are currently being developed, cannabis possession will be degraded from the highest status of crime to the lowest one, called "contravention" in the French judiciary system. As such, violators will no longer be subject to imprisonment; instead, people found in possession of marijuana will simply have to pay a fine of €100 ($111).

Thu
25
May

Cannabidiol reduces seizures in kids with severe form of epilepsy, trial shows

A medicine made from marijuana, without the stuff that gives a high, cut seizures in kids with a severe form of epilepsy in a study that strengthens the case for more research into pot's possible health benefits.

"This is the first solid, rigorously obtained scientific data" that a marijuana compound is safe and effective for this problem, said one study leader, Dr. Orrin Devinsky of NYU Langone Medical Center.

He said research into promising medical uses has been hampered by requiring scientists to get special licenses, plus legal constraints and false notions of how risky marijuana is.

Wed
24
May

Europe: Cannabis Isn't the Health Problem - It's the Tobacco You Mix with It

Europe may seem like an increasingly divided continent, but there is one thing that unites its people: an obsession with using tobacco to smoke cannabis. Up to 90% of Europeans combine tobacco with cannabis, according to the latest Global Drug Survey. By comparison, only 8% of Americans smoke cannabis this way.

Cannabis is illegal in the UK – and many other European countries – and it has known harms, but the reality is that many people use the drug anyway. Consequently, policy needs to reflect this reality.

Wed
24
May

Australian MMJ Skin Care Line Expected Throughout Europe This Year

MGC Pharmaceuticals are on track to launch their dermatological product range in Europe in the third quarter of 2017 after producing a solid set of results from a final clinical trial.

Three products in the company’s DermaPlus product range were tested on 90 volunteers over a threemonth period with the independent trial conducted by Dr Rok Devjak at a leading dermatological clinic in Solvenia.

According to the company the results were very positive and the latest endorsement of MGC Pharma’s claims of the medicinal and healing powers of cannabis. 

Pages

Subscribe to RSS - Europe